← All trials
NCT01573429
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 18, 2012
- Primary completion
- Jun 16, 2020
- Completion date
- Jun 16, 2020
- First posted
- Apr 9, 2012
- Last posted
- Nov 18, 2021
- Enrollment
- 38
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- National Institute of Environmental Health Sciences (NIEHS)Lead sponsor
- National Institute of Environmental Health Sciences (NIEHS)Overall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.